NLNadezhda Vasilievna Lafutkina

Nadezhda Vasilievna Lafutkina

*This is an algorithmically generated author record based on publicly available information.

Nadezhda Vasilievna Lafutkina has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Evaluation of the effectiveness of adjuvant conservative therapy in combination with balloon dilatation in limited larynx and tracheal stenosis

    by E.A. Kirasirova, N.V. Lafutkina, R.F. Mamedov, O.K. Piminidi, S.I. Tyutina, E.V. Kulabukhov, O.V. Shulga, T.M. Suslova

    Background. Localized cicatricial stenosis of the larynx and trachea remains a challenging clinical problem due to the high rate of recurrence following endoscopic interventions. Developing effective adjuvant therapies aimed at preventing restenosis is a pressing task. Objective. To evaluate the efficacy of a newly developed adjuvant therapy algorithm combined with surgical treatment for localized laryngeal and tracheal stenosis. Material and methods. The study, conducted between 2023 and 2025 at the Sverzhevsky Research Clinical Institute of Otorhinolaryngology, included 35 patients (9 men, 26 women; mean age 46.3±9.7 years) with localized cicatricial stenosis of the larynx and trachea (post-intubation: 40%; granulomatosis with polyangiitis: 34%; idiopathic: 26%). Patients were divided into two groups. The study group (n=20) underwent balloon dilation combined with the developed adjuvant therapy, which included the intraoperative administration of 1 ml of triamcinolone (40 mg/ml) and a course of bovhyaluronidase azoximer 3000 IU (5 injections at 3-day intervals, starting on the 4th postoperative day, with a repeat course after 14 days). The comparison group (n=15) received only surgical treatment with standard pharmacological support. Efficacy was assessed using the mMRC scale, as well as endoscopic and CT data, at the 12-month follow-up. Results. At baseline, the mean mMRC score was 2.9±0.6 for all patients. One month after treatment, the parameters had improved in both groups (study group: 1.1±0.4; comparison group: 1.2±0.5, p=0.28). At 12 months, dyspnea in the study group had decreased to 0.9±0.3, whereas in the comparison group, the score remained higher at 1.4±0.7 (p=0.02). Airway lumen restoration at 6—12 months was 85±10% in the study group versus 65±15% in the control group (p<0.05). In the comparison group (n=15), two patients required the removal of excess fibrin masses. During the 12-month follow-up, recurrence developed in only one patient (5%) in the study group—a patient with granulomatosis with polyangiitis. In the control group, restenosis of varying severity occurred in four patients (26.6%); three required repeat balloon dilation, and one required the removal of granulation tissue. Tolerability of the adjuvant therapy was satisfactory; no serious adverse events were recorded. The use of adjuvant therapy in the study group resulted in a lower recurrence rate and better functional outcomes. Conclusion. The developed combined treatment algorithm, which combines balloon dilation with adjuvant therapy using triamcinolone and bovhyaluronidase azoximer, has demonstrated high clinical efficacy and safety in the treatment of limited laryngeal and tracheal stenosis.

  • Minimally invasive surgical treatment for bilateral laryngeal paralysis

    by E.A. Kirasirova, T.M. Suslova, R.F. Mamedov, O.K. Piminidi, N.V. Lafutkina, R.A. Rezakov, E.V. Kulabukhov, V.A. Trusov, O.V. Shulga

    This article discusses a surgical treatment method for bilateral laryngeal paralysis involving the use of a TrueBlue laser and vocal fold laterofixation. The results of minimally invasive surgical treatment for 30 patients with bilateral laryngeal paralysis—primarily caused by thyroid surgery—are presented. The method’s efficacy was comprehensively evaluated over time using both subjective and objective assessment techniques. The results demonstrated improvements in respiratory function and quality of life, and enabled successful decannulation for all patients who had previously undergone tracheostomy. The surgical technique employed proved to be both effective and safe for restoring laryngeal function.

  • An integrated approach to the management of patients with laryngeal and tracheal stenosis: from surgical reconstruction to drug prevention of relapses

    by E.A. Kirasirova, N.V. Lafutkina, R.F. Mamedov, O.K. Piminidi, S.I. Tyutina, E.V. Kulabukhov, O.V. Shulga, T.M. Suslova

    Objective. To evaluate the effectiveness of combination therapy based on triamcinolone and bovhyaluronidase azoximer in the treatment of patients with cicatricial stenosis of the larynx and trachea. Material and methods. The study included 30 patients with cicatricial stenosis of the larynx and trachea, aged 18—70 years. All patients underwent primary laryngotracheoplasty followed by stenting. In addition to standard postoperative therapy, all patients received adjuvant antifibrotic therapy with triamcinolone and bovhyaluronidase azoximer according to the developed regimen. Efficacy was assessed by visual control of healing, endoscopic monitoring of the airway lumen over 12 months, and the SF-36 quality of life questionnaire before and after treatment. Results. According to visual assessment of the healing process, the exudation phase asted with a mean of 4.2±1.1 days, and postoperative pain subsided on day 5. Fibrin reorganization and epithelialization were achieved by days 9—12. Excessive growth of granulation tissue was observed in only 3 (10%) patients and was successfully controlled with additional injections of triamcinolone. Endoscopic monitoring revealed a low restenosis rate (6.7%), with the lumen remained stably patent in 93.3% of patients. Complete decannulation was achieved in 50% of the cohort. Results of the SF-36 questionnaire showed a significant improvement in quality of life: scores on the physical and social functioning scales increased more than 1.5-fold. This indicates a reduction in psychological distress and the patients’ successful reintegration into social life. Conclusion. Combined use of adjuvant therapy with triamcinolone and bovhyaluronidase azoximer reduced the incidence of restenosis and significantly improved the postoperative outcomes. Accelerated healing, minimized complication rates, and a significant improvement in quality of life confirm the high clinical efficacy of the developed treatment algorithm for treating patients with cicatricial stenosis of the larynx and trachea.

  • Evolution of surgical treatment of bilateral laryngeal paralysis

    by E.A. Kirasirova, O.K. Piminidi, T.M. Suslova, R.F. Mamedov, N.V. Lafutkina, S.I. Tyutina, R.A. Rezakov, E.V. Kulabukhov, V.A. Trusov, O.V. Shulga

    The presented article discusses a range of issues related to bilateral laryngeal paralysis (BLP), focusing on existing surgical treatment methods. According to the literature studied, significant progress has been made in the treatment of BLP, ranging from open operations with tracheostomy to minimally invasive methods of modern laryngeal surgery using laser technology and endoscopy. The results of surgical treatment of more than 50 patients are presented. The advantages and disadvantages of existing surgical approaches are highlighted. The review highlights the importance of further scientific research and the development of innovative methods for restoring laryngeal innervation aimed at improving the effectiveness of treatment and improving the quality of life of patients with BLP.


  • Nodular form of idiopathic reactive lymphoid hyperplasia of the vestibular part of the larynx

    by E.A. Kirasirova, O.K. Piminidi, T.N. Sotnikova, R.F. Mamedov, N.V. Lafutkina, S.I. Tyutina, R.A. Rezakov, E.V. Kulabukhov, V.A. Trusov, O.V. Shulga, et al.

    Laryngeal lymphoid hyperplasia is an extremely rare pathology, and clinical cases of this pathology described in the literature are limited. This article presents a clinical case of a patient with nodular idiopathic reactive lymphoid hyperplasia of the vestibular larynx. Patient G., 53 years old, was admitted to the department in April 2024 complaining of tracheostomy, difficulty swallowing, hoarseness. After the examination, the diagnosis was established: neoplasm of the larynx. Laryngeal stenosis. Tracheostomy. A neoplasm removal was performed via direct laryngoscopy under general anesthesia using radiofrequency device Surgitron and an ARC TrueBlue 445 nm surgical laser. The morphological picture was similar to a lymphoproliferative disorder. However, immunohistochemical reactions with antibodies to bcl-6 (clone GI191E/A8, Cell Marque Corporation) and to bcl-2 (clone 124, Cell Marque Corporation) canceled the diagnosis of lymphoma and established the diagnosis of supraglottic submucosa nodular idiopathic reactive lymphoid hyperplasia. The patient was decannulated and fully rehabilitated. Idiopathic lymphoid hyperplasia of the larynx is an extremely rare cause of airway stenosis that requires surgical intervention. The diagnosis should be differentiated with lymphoproliferative disorders and with foci of ectopic tonsil tissue. The diagnosis should be based on a thoroughly conducted histological examination with immunohistochemical reactions.


  • Modern conservative therapy of scar stenosis of the larynx and trachea. Literature review

    by E.A. Kirasirova, O.V. Shulga, N.V. Lafutkina, R.F. Mamedov, O.K. Piminidi, S.I. Tyutina, D.A. Iumatova, V.A. Trusov

    The article presents a review of the literature, in which the possibilities of conservative therapy in the treatment of chronic scar stenosis of the larynx and cervical trachea are considered. Due to the high risk of restenosis of the larynx and cervical trachea lumen in the postoperative period, the problem under consideration remains topical. The authors have systematised modern literature data on the groups of used drugs, mechanisms of action and routes of delivery, advantages and disadvantages, and reviewed the experience of their use in otorhinolaryngology.


  • A new approach to surgical treatment of extended chronic cicatricial stenosis of the larynx and trachea

    by A.I. Kryukov, E.A. Kirasirova, N.V. Lafutkina, O.K. Piminidi, R.F. Mamedov, R.A. Rezakov, S.I. Tyutina, V.A. Trusov, O.V. Shulga, T.M. Suslova, et al.

    Objective. To develop an algorithm for surgical treatment and postoperative management of patients with prolonged chronic cicatricial stenosis of the larynx and trachea and evaluate its effectiveness. Material and methods. To achieve the goal we examined and treated 88 patients with chronic cicatricial stenosis of the larynx and trachea. Results. The algorithm of complex treatment of patients with chronic cicatricial stenosis of the larynx and trachea has been improved based on a differentiated approach to surgical treatment using various implantation materials, and new methods of postoperative management of patients have been developed: a silicone stent for postoperative prosthetics of the formed laryngeal lumen and a dressing based on sodium alginate. Conclusion. With the help of a new algorithm of complex treatment of patients with chronic cicatricial stenosis of the larynx and trachea, surgical tactics and conservative management of patients in the postoperative period were optimised, which allowed to rehabilitate more patients, reduce the number of reoperations, shorten hospitalisation periods and economic costs.

  • Reconstructive and plastic treatment of extensive laryngotracheostomy following mine blast injury

    by Elena A. Kirasirova, Ramis Firudunovich Mamedov, Nadezhda Vasilievna Lafutkina, Olga Kuzminichna Piminidi, Svetlana Igorevna Tyutina, Vladislav Alekseevich Trusov, Alexandra Denisovna Krokhmal

    BACKGROUND: The nature of combat operations in modern military conflicts is leading to an increase in the number of casualties due to mine blast trauma. Combat wounds to the neck are often associated with damage to the larynx and trachea, resulting in scarring airway stenosis. Surgery is the primary treatment for chronic scarring stenosis of the larynx and trachea. However, despite the large number of surgical techniques, not all of them are effective. Anatomic features of the larynx and trachea, difficulties in maintaining the formed airway lumen in most cases lead to postoperative restenosis of the larynx and trachea, which significantly reduces the effectiveness of surgical treatment and complicate the rehabilitation of the patient. CLINICAL CASE DESCRIPTION: This article presents the experience of treating an extensive laryngotracheal defect resulting from a mine blast injury. A patient with an extensive defect of the anterior wall of the larynx and trachea was admitted to the Department of Reconstructive Surgery of Cavitary Organs of the Neck of L.I. Sverzhevsky Research Clinical Institute of Otolaryngology. After clinical evaluation, laryngotracheoplasty was performed with alloimplant material, followed by stenting of the lumen of the larynx and trachea with a specially developed silicone stent. CONCLUSION: The use of the most advanced medical technologies allowed to achieve a positive clinical outcome, to reduce the number of stages of surgical treatment, to prevent restenosis of the lumen of the larynx and trachea, to restore breathing through the natural ways of breathing, the physiological process of swallowing and the voice of the patient.


  • Methods of stenting the laryngeal-tracheal lumen after reconstructive surgical interventions. Literature review

    by E.A. Kirasirova, R.F. Mamedov, N.V. Lafutkina, O.K. Piminidi, R.A. Rezakov, S.I. Tyutina, V.A. Trusov, O.V. Shulga

    The article presents a literature review that analyzes methods of stenting the laryngeal-tracheal lumen after reconstructive surgical interventions. 49 literature sources were studied. The advantages and disadvantages of existing stents are determined. The choice of the optimal method of stenting, which contributes to the formation of a stable physiological lumen of the larynx and trachea, determines the relevance of the problem raised.

  • The use of the dura mater at the final stage of reconstructive plastic surgical treatment of cicatricial stenosis of the larynx and trachea

    by E.A. Kirasirova, S.I. Tyutina, A.S. Mironov, N.V. Borovkova, N.V. Lafutkina, R.F. Mamedov, R.A. Rezakov, E.A. Frolkina, D.A. Yumatova

    The article presents an analysis of the plastic reconstructive surgery effectiveness for patients with an extended tracheal defect using an allograft based on the dura mater (DM) at the final stage of surgical treatment of laryngeal and tracheal cicatricial stenosis. The study included 20 patients with cicatricial stenosis of the larynx and trachea, who were previously performed plastic reconstructive treatment with scar tissue excision in the lumen of the respiratory tract and restoration of the supporting frame of the larynx and trachea using allografts based on costal allocartilage. The age of the patients ranged from 21 to 54 years, the duration of the disease was from 1 to 5 years. After a standard clinical and laboratory examination, with a mandatory video endoscopic examination of the larynx and trachea, multislice computed tomography of the larynx and trachea, patients underwent plastic closure of the tracheal defect using DM. Dynamic outpatient monitoring was carried out once a week for 1 month, once a month for 3 months, control examination was done 6 months after surgical treatment. The results of the study demonstrated a full-fledged social and labor rehabilitation of all 20 patients after the final stage of surgical treatment using DM, the absence of rejection reaction and migration of allo-implantation material, the preserved lumen of the larynx and trachea with a rigid supporting skeleton and the absence of anterior tracheal wall floatation. The use of DM as an additional strengthening of the anterior tracheal wall for patients with deficiency of muscular aponeurotic tissues and more than 2 cm size tracheal defect is highly effective at the final stage of surgical treatment for plastic closure of the tracheal defect.